key: cord-0684853-b419ofv5 authors: Tang, Fei‐Fei; Zhao, Xiao‐Su; Xu, Lan‐Ping; Zhang, Xiao‐Hui; Chen, Yu‐Hong; Mo, Xiao‐Dong; Liu, Kai‐Yan; Huang, Xiao‐Jun title: Utility of flexible bronchoscopy with polymerase chain reaction in the diagnosis and management of pulmonary infiltrates in allogeneic HSCT patients date: 2017-12-01 journal: Clin Transplant DOI: 10.1111/ctr.13146 sha: 7eaa12354fd54ba34422857646ab8acdef19a472 doc_id: 684853 cord_uid: b419ofv5 OBJECTIVES: Pulmonary infiltrates in allogeneic hematopoietic stem cell transplant (allo‐HSCT) patients are potentially life‐threatening and require early diagnosis and treatment. We aimed to retrospectively explore the clinical efficacy of polymerase chain reaction (PCR) in conjunction with flexible bronchoscopy (FB) in allo‐HSCT patients with pulmonary infiltrates. PATIENTS AND METHODS: We retrospectively reviewed all patients undergoing FB after allo‐HSCT at the Peking University Institute of Hematology from January 2013 to December 2016. We used PCR to detect various viruses in FB specimens, particularly for 27 viruses. RESULTS: One hundred forty‐nine diagnostic FBs were performed in 130 patients. The overall diagnostic yield was 58%. Eighty‐nine percent of the patients with a positive FB result were diagnosed with a pulmonary infection. Viruses were the most common infectious diagnosis (70%), followed by fungi (48%), bacteria (38%), and Pneumocystis jirovecii (12%). Multivariate analyses showed that a chest computed tomography (CT) finding of diffuse pulmonary infiltrates (P = .012) and positive results in assisted microbiological and serological analyses (P = .000) predicted a positive FB result. FB results prompted a treatment modification in 61% of cases. CONCLUSIONS: FB in conjunction with PCR is efficient in the rapid diagnosis and management of pulmonary infiltrates in allo‐HSCT patients. Bronchoscopies were performed by a respiratory physician using a flexible fiber-optic bronchoscope (Olympus). Procedures were performed through the nasal or oral cavity following local anesthesia (lidocaine 2%) and were supported with cardiopulmonary monitoring (continuous assessment of pulse rate, blood pressure, and oxygen saturation). All FB samples were obtained from areas of lung infiltration. If multiple areas were present, samples were obtained from the area where the infiltration was most severe. Various flexible bronchoalveolar procedures, including bronchoalveolar lavage (BAL), protected sample brushing (PSB), and transbronchial biopsy (TBB), have been used to establish a diagnosis. The decision to request PSB or TBB was made by the respiratory physician responsible for the FB. Among patients who underwent multiple FBs, each procedure was recorded and considered independently. Blood and FB samples were routinely subjected to the following tests: Bacterial pneumonia was defined as the presence of a positive FB culture and/or PCR when strong clinical suspicion of lower respiratory tract infection (eg, the presence of fever, cough, purulent sputum, pleurisy, or leukocytosis). Fungal pneumonia was defined as a positive FB culture for any mold or rare yeast. Invasive pulmonary aspergillosis (IPA) was defined according to the revised EORTC/MSG criteria, 17 A polymicrobial pulmonary infection was defined as the identification of two or more infectious agents based on the above criteria. The diagnostic yield of FB was considered to be the proportion of cases with a specific diagnosis. Diffuse alveolar hemorrhage (DAH) was defined by BAL samples with increasingly bloody return (three separate samples were required) or by the presence of 20% or more hemosiderin-laden macrophages. 18 Data were censored at the time of death or the last available followup. Continuous variables were compared using the Mann-Whitney U test; categorical variables were compared using the chi-squared test and Fisher's exact test. The Kaplan-Meier method was used to estimate the probability of OS. Univariate analysis was performed using binary logistic regression, calculating the odds ratios (OR) with 95% confidence intervals (CI) and P-values. Multivariable stepwise logistic regression analysis was used to assess the relationship between patient characteristics and positive FB result. P < .05 was considered statistically significant. We attempted to enter all variables with a P-value<.1 in the univariate analysis into the multivariate analysis using the logistic regression. All P-values were obtained using 2-sided hypothesis tests. The data analyses were conducted primarily using the Statistical Package for the Social Sciences (SPSS) software (SPSS Inc., Chicago, IL, USA). Only three asymptomatic patients were referred for FB when abnormalities were discovered incidentally upon CT, while other patients (n = 127) had a fever or chest symptoms, such as cough, sputum production, dyspnea, and pleuritis. At the time of bronchoscopy, 22% of the patients (n = 29) were neutropenic, while seven patients (5%) were severe neutropenia (ANC <0.5 × 10 9 /L). Thrombocytopenia was common (median platelet count of 69 × 10 9 /L, range 10-391 × 10 9 /L). One hundred nineteen (92%) CT showed diffuse bilateral infiltrates. All patients received empirical antimicrobial therapy prior to FB. The median duration of antimicrobial therapy before FB was 15 days (range 0-93 days). These therapies included broad-spectrum antibiotics (n = 127, 98%), antifungals (n = 123, 95%), antivirals (n = 85, 65%), and anti-P. jirovecii agents (n = 79, 61%). Thirty patients received mechanical ventilation in an intensive care unit before FB. The univariate analysis demonstrated that non-ISD (P = .012), CT findings of diffuse infiltrates (P = .003), PLT<50 × 10 9 /L (P = .072), and positive assisted microbiological and serological analyses (P = .000) were statistically or marginally associated with a higher likelihood of obtaining a positive FB result (Table 3 The overall treatment modification after FB was 61% (n = 79): 73% We firstly used PCR to identify 27 viruses in FB specimens to evaluate pulmonary infiltrates in allo-HSCT patients. In this large single-center study of 130 consecutive patients, the overall diagnostic yield of FB was 58%. FB results prompted a treatment modification in 61% of cases. Eighty-nine percent of positive FB results were infections. A polymicrobial etiology was established in 47% of these cases. Viruses were the most common infectious diagnosis (70%), followed by fungi (48%), bacteria (38%), and P. jirovecii (12%). We attempted to combine the results from BAL, PSB, and TBB in conjunction with PCR to enhance the diagnostic yield of FB compared to other studies, which have reported diagnostic yields of 23%-65%. [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] However, the present study did not demonstrate a superior diagnostic yield. Several explanations may account for this outcome. First, the small size of PSB and TBB and the strict definitions for bacterial, viral, and fungal pneumonia could explain why a higher diagnostic yield was not attained in the present study, despite the use of a wide range of molecular diagnostic tests. Second, all patients received empirical antimicrobial therapy prior to FB, which had the potential to decrease the diagnostic yield. Most of FB results corresponded to infectious microorganisms. Overall, 142 pathogens were considered relevant and were mainly viruses. There were significantly more viruses detected in our study than in previous studies. 7, 12, 16 Several explanations may account for this outcome. First, bacterial and fungal infections are the primary causes of infection during neutropenic period, while viral infections are more common during the mid-and late-recovery phases after HSCT. [4] [5] [6] 9, 11 Majority of patients in our study were non-neutropenic. Second, compared with previous studies, we used PCR to detect 27 viruses, which greatly improved the diagnosis of viruses and allowed the early administration of appropriate therapies. However, these assays were not available during the previous study periods. The results demonstrate that PCR is a fast and effective diagnostic method for viruses. In our study, CMV was the most common pathogen found, which is in agreement with previous studies, 7,16 followed by RSV and parainfluenza virus. Aspergillus pneumonia accounted for 62% of all fungal pneumonia and was the most common co-pathogen in the polymicrobial pulmonary infection group (42%), which may correlate with the relatively higher proportion of haplo-HSCT (74%) in our study. In accordance with previous studies, the threshold value for positive BAL GM in our study was 0.5. 6, 19 PJP was found in a relatively high percentage (12%). In our study, the diagnosis of PJP was confirmed by PCR in 8/9 (89%) cases, which confirmed that PCR was relatively sensitive for the de- The 7% incidence of DAH in our observation is consistent with the incidence of 1%-20% reported in the literature. 21, 22 FB results prompted a treatment modification in 61% of cases, which is higher than 29%-51% reported previously. [4] [5] [6] [7] [8] 10, 12, 13 The changes most frequently identified were modifications to anti-infection treatments, especially antiviral treatments. The modifications in positive FB groups were significantly higher than negative FB groups, while there was no significant difference in the 30-day mortality rates between two groups. All of these results prove that PCR in FB is a fast and effective diagnostic method for identifying viruses and allows the early administration of appropriate therapies, thereby eliminating the pathogen. Our study showed that the diagnostic yield of FB for diffuse infiltrates was better than that for focal infiltrates. This is consistent with the findings of Seneviratna et al 10 and Lanino et al. 23 This reason for this result may be that diffuse infiltrates have a greater probability of having an infectious cause and a high pathogen burden than do focal infiltrates. In addition, a notable difference in our study compared with previous reports is that the group with positive results in the assisted microbiological and serological analyses was associated with a higher likelihood of obtaining a positive FB. It may also be explained by a higher probability of having an infectious basis. The limitations of our study are multifactorial. First, this is a retrospective single-center study. Second, the most important limitation of this study is no consensus regarding the optimal timing for FB in allo-HSCT recipients at our center, which may introduce bias. Third, although we defined treatment modifications as changes introduced within 3 days after FB, we did not have a definitive way to ensure that these changes were all accurate given the retrospective nature of the study. Finally, our study did not represent the incidence of pneumonia following allo-HSCT, because this would require an analysis of all allo-HSCT patients with new pulmonary infiltrates. In summary, this large single-center study firstly used PCR to identify 27 viruses in FB samples to evaluate pulmonary infiltrates in allo-HSCT population. We confirmed that FB in conjunction with PCR is efficient in the rapid diagnosis and management of pulmonary infiltrates in allo-HSCT patients. Pulmonary complications in adult blood and marrow transplant recipients: autopsy findings Pulmonary infiltrates in patients with haematologic malignancies: clinical usefulness of non-invasive bronchoscopic procedures Bronchoalveolar lavage and lung biopsy in patients with cancer and hematopoietic stemcell transplantation recipients: a systematic review and meta-analysis Does molecular analysis increase the efficacy of bronchoalveolar lavage in the diagnosis and management of respiratory infections in hemato-oncological patients? Utility of flexible bronchoscopy in the evaluation of pulmonary infiltrates in the hematopoietic stem cell transplant population -a single center fourteen year experience Diagnostic value of bronchoscopy in patients with hematologicmalignancy and pulmonary infiltrates The clinical importance of bronchoalveolar lavage in allogeneic SCT patients with pneumonia Utility of early versus late fiberoptic bronchoscopy in the evaluation of new pulmonary infiltrates following hematopoietic stem cell transplantation Diagnostic value of bronchoalveolar lavage in leukemic and bone marrow transplant patients: the impact of antimicrobial therapy Diagnostic yield of bronchoscopic sampling in febrile neutropenic patients with pulmonary infiltrate and haematological disorders Survey of academic pulmonologists, oncologists, and infectious disease physicians on the role of bronchoscopy in managing hematopoietic stem cell transplantation patients with pulmonary infiltrates Association of bronchoalveolar lavage yield with chest computed tomography findings and symptoms in immunocompromised patients Utility of bronchoalveolar lavage in diagnosing respiratory tract infections in patients with hematological malignancies: are invasive diagnostics still needed? Superior graft-versus-leukemia effect associated with transplantation of haploidentical compared with HLAidentical sibling donor grafts for high-risk acute leukemia: an historic comparison Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study Late-onset severe pneumonia after allogeneic hematopoietic stem cell transplantation:prognostic factors and treatments Revised definitions of invasive fungal disease from the european organization for research and treatment of cancer/invasive fungal infections cooperative group and the national institute of allergy and infectious diseases mycoses study group (eortc/msg) consensus group Diffuse alveolar hemorrhage following allogeneic bone marrow transplantation in children Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients Polymerase chain reactionbased detection of Pneumocystis jirovecii in bronchoalveolar lavage fluid for the diagnosis of pneumocystis pneumonia Diffuse alveolar hemorrhage in hematopoietic stem cell transplant recipients Increasing incidence of diffuse alveolar hemorrhage following allogeneic bone marrow transplantation: cryptic etiology and uncertain therapy Fiberoptic bronchoscopy and bronchoalveolar lavage for the evaluation of pulmonary infiltrates after BMT in children Utility of flexible bronchoscopy with polymerase chain reaction in the diagnosis and management of pulmonary infiltrates in allogeneic HSCT patients None.